Paradigm Biocapital Advisors LP Insmed Inc Transaction History
Paradigm Biocapital Advisors LP
- $2.67 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
339Shares Held
141MCall Options Held
2.25MPut Options Held
3.11M-
Vanguard Group Inc Valley Forge, PA14.5MShares$972 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$791 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$722 Million0.04% of portfolio
-
State Street Corp Boston, MA5.91MShares$396 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.78MShares$321 Million4.29% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.08B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...